WO2025180452 - WRN INHIBITOR COMPOUND AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/180452
Publication Date
04.09.2025
International Application No.
PCT/CN2025/079599
International Filing Date
27.02.2025
Title **
[English]
WRN INHIBITOR COMPOUND AND USE THEREOF
[French]
COMPOSÉ INHIBITEUR DE WRN ET SON UTILISATION
[Chinese]
WRN抑制剂化合物及其应用
Applicants **
NANJING ZAIMING PHARMACEUTICAL CO., LTD.
Inventors
WANG, Weikun
WANG, Juan
SUN, Tianwen
ZHAO, Zihao
ZHENG, Yang
WU, Jinjin
SHAN, Jinwen
ZHU, Wei
YU, Jian
LI, Zhengtao
TANG, Renhong
Priority Data
202410231931.6
29.02.2024
CN
202410332343.1
21.03.2024
CN
202410513176.0
26.04.2024
CN
202410651779.7
24.05.2024
CN
202410847628.9
27.06.2024
CN
202410998367.0
24.07.2024
CN
202411615991.4
13.11.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2890 | |
| EPO | Filing, Examination, Granting | 17234 | |
| Japan | Filing, Examination, Granting | 2366 | |
| South Korea | Filing, Examination, Granting | 2690 | |
| USA | Filing, Examination, Granting | 5390 |
Total:
30,570
Contact Us
Abstract[English]
Provided in the present disclosure are a WRN inhibitor compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and the use thereof as a WRN inhibitor in the prevention or treatment of related diseases.[French]
La présente invention concerne un composé inhibiteur de WRN tel que représenté dans la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, une composition pharmaceutique le contenant, et son utilisation en tant qu'inhibiteur de WRN dans la prévention ou le traitement de maladies associées.[Chinese]
本公开提供了一种式(I)所示的WRN抑制剂化合物或其药学可接受的盐，含有它们的药物组合物以及其作为WRN抑制剂在预防或治疗相关疾病中的应用。